Founder and endocrinologist with 10 years of experience at AZ St-Lucas Gent in Belgium, specializes in diabetes technology and is the chairman of the Belgian Society of Endocrino-Diabetologists. She is known for her passion and positive, dynamic approach to care.

A pediatrician-diabetologist and founder of Diabeter, an independent treatment center focused on the treatment of type 1 diabetes in the Netherlands, is dedicated to helping patients with type 1 diabetes and is known for his expertise and compassionate approach to patient care.

An enthusiastic endocrinologist at OLV Hospital Aalst in Belgium with a strong interest in diabetes technology, is well-regarded for her patient-oriented perspective, expertise and passion for improving patient outcomes through technology.

Head of the Diabetology Clinic at Hôpital Erasme in Brussels and president of the Association Du Diabète, is a respected leader in the field of diabetes care and known for his expertise, commitment to innovation, and patient-centered approach to care.

Prof. Dr. Lutz Heinemann is a renowned scientist and former CEO of Profil Institut für Stoffwechselforschung GmbH. He is currently a partner and scientific consultant at Profil Institut für Stoffwechselforschung and Profil Institut for Clinical Research Ltd., and was the coordinator for the EU-funded Research Project AP@home from 2010-2015. Additionally, he serves as the Managing Editor of the Journal of Diabetes Science and Technology since August 2011.

Melissa Holloway is a passionate diabetes advocate, having lived with type 1 diabetes since 1994 and working in the diabetes care industry since 2003. She specializes in communicating about diabetes technology, including insulin pump therapy, CGM, and DIY artificial pancreas systems. From 2013 to 2018, she helped run the UK diabetes technology access advocacy organization, INPUT (now part of JDRF UK). Born and raised in Virginia in the US, she currently resides in central London with her husband and two young children.

_{^{Dr. Henk-Jan Aanstoot
The Netherlands}}

_{^{Dr. Henk-Jan Aanstoot is a pediatrician-diabetologist and founder of Diabeter, an independent treatment center focused on the treatment of type 1 diabetes in the Netherlands. He is dedicated to helping patients with type 1 diabetes and is known for his expertise and compassionate approach to patient care.}}

_{^{Declaration of Conflict of Interest
The reviewer has received a consultation fee of Novo Nordisk, Medtronic and Dexcom. Medtronic is shareholder in the Diabeter Clinic.}} 

_{^{Declaration of Financial Support
The reviewer did not receive financial support of DiabetoTech for his contribution to the Diabetes Technology Expert Program.}}

_{^{Sjoerd Aerts
The Netherlands}}

_{^{Since 2019 Diabetes type 1 (Lada).
From early 2021 use in Medtronic's Minimed 780G system with CGM (Guardian 4 sensor) Before pen therapy.}}

_{^{Declaration of Conflict of Interest
Active (voluntary) in diabetes world. As a volunteer at Diabetesplus (PompBuddy and SportBuddy and webmaster) and 1 of the administrators of the 780G group of the Netherlands and Belgium on Facebook (4K members).}}

_{^{Declaration of Financial Support
The reviewer receives financial support of DiabetoTech for his contribution to the Diabetes Technology Expert program}}

_{^{Vanessa Buitendijk
Netherlands}}

_{^{Vanessa Buitendijk has firsthand experience managing Type 1 diabetes since 1996. Her expertise spans various pump models, including the Accu-Chek Insight, mylife Ypsopump, and now, the Kaleido pump. Recently, Vanessa has embraced the integration of cutting-edge technologies, currently utilizing the Kaleido pump alongside Diabeloop and the Dexcom G6 sensor since March 2024. With her wealth of knowledge and practical insights, Vanessa brings invaluable perspective to our course review process, ensuring relevance and accuracy for learners seeking to enhance their understanding of diabetes management.}}

_{^{Disclosures
No disclosures}}

_{^{Declaration of Financial Support
No financial contribution.}}

_{^{Miroslava Calegari
Slovakia}}

_{^{Disclosures
Miroslava is a caregiver to DIY Looper and her life is split between Slovakia and Italy. She is an administrator of the "Loop and Learn Italia" Facebook group, Loop and Learn Facebook group Moderator, @loopandlearn Instagram content creator and a part of #dedoc voices program, an initiative of #dedoc.}}

_{^{Professional interpreter and translator, a Certified Diabetes Educator, with a passion for lifelong learning. Committed to bridging language gaps and providing support to others facing similar challenges.}}

_{^{Declaration of Financial Support
The reviewer did not receive financial support of DiabetoTech for her contribution to the Diabetes Technology Expert Program.}}

_{^{Meg Cremins
London, UK}}

_{^{Meg Cremins was diagnosed with type 1 diabetes at the age of 5 and Celiac disease at the age 15. After struggling throughout her teenage years with her diabetes management, she now shares her journey about living a healthy, balanced, and joy-filled life on her blog Beets and Betes and on her Instagram account. She is currently pursuing her master’s degree in Food Science in Nutrition with career goals to become a Registered Dietitian and certified diabetes care and education specialist to help other people living with diabetes live active, happy, and healthy lives.}}

_{^{Disclosures
No disclosures}}

_{^{Declaration of Financial Support
The reviewer did receive financial support of DiabetoTech for her contribution to the Diabetes Technology Expert Program}}

_{^{Prof Dr Laurent Crenier
Brussels, Belgium}}

_{^{Prof. Dr. Laurent Crenier is Head of the Diabetology Clinic at Hôpital Erasme in Brussels and president of the Association Du Diabète. He is a respected leader in the field of diabetes care and known for his expertise, commitment to innovation, and patient-centered approach to care.}}

_{^{Declaration of Conflict of Interest
The reviewer received a grant from Roche for clinical research, speaker fees from Medtronic & Abbott and is member of the advisory board of Abbott}}

_{^{Declaration of Financial Support
The reviewer did not receive financial support of DiabetoTech for his contribution to the Diabetes Technology Expert Program}}

_{^{Justin Eastzer
USA}}

_{^{Justin Eastzer, aka @diabe_tech, is a diabetes journalist and storyteller. He was diagnosed with T1D LADA at the age of 30 with the help of the diabetes community on Tik Tok. Now, he continues to share his story and others’ on his podcast, YouTube channel, and social pages called Diabetech.}}

_{^{Declaration of Conflict of Interest
The reviewer is a paid spokesperson for Dexcom and received project fees from Insulet.}}

_{^{Declaration of Financial Support
The reviewer received financial support of DiabetoTech for his contribution to the Diabetes Technology Expert program.}}

_{^{Diana Isaacs
USA}}

_{^{Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP is an Endocrinology Clinical Pharmacy Specialist. She is the Co-Director of Endocrine Disorders in Pregnancy at the Cleveland Clinic Endocrinology and Metabolism Institute.  She is also the Director of Education & Training in Diabetes Technology. Dr. Isaacs earned her bachelor’s degree in Chemistry from the University of Illinois at Chicago, Doctor of Pharmacy Degree from Southern Illinois University Edwardsville (SIUE) and completed a pharmacy practice residency at the Philadelphia VA. Dr. Isaacs holds board certifications in pharmacotherapy, ambulatory care, and advanced diabetes management. She served on the American Diabetes Association (ADA) Professional Practice Committee from 2020-2023, the committee that updates the ADA Standards of Care. She is also a National Board Member of the Association of Diabetes Care and Education Specialists (ADCES).  She advocates access and choice to the latest technologies and therapeutics for all people with diabetes and speaks on diabetes related topics nationally and internationally. She was the ADCES Diabetes Care and Education Specialist of the Year in 2020 and inducted into the SIUE Hall of Fame in 2022 for her far reaching contributions in diabetes care.}}

_{^{Disclosures
Speaker or consultant for: Dexcom, Abbott, Lilly, Novo Nordisk, Medtronic, Insulet, Ascensia, Cequr}}

_{^{Declaration of Financial Support
The reviewer received no financial support of DiabetoTech for his contribution to the Diabetes Technology Expert program.}}

_{^{Ilse Faber
The Netherlands}}

_{^{Ilse Faber is 23 years old and has type 1 diabetes for over 5 years.}}

_{^{Declaration of Conflict of Interest
The reviewer is a volunteer at Diabetes+, a Dutch diabetes foundation for and by people with type 1 diabetes and she blogs about her life with type 1}}

_{^{Declaration of Financial Support
The reviewer receives financial support of DiabetoTech for her contribution to the Diabetes Technology Expert program}}

_{^{Renate Groenendijk
The Netherlands}}

_{^{Renate Groenendijk is diabetes coach, insulin pump instructor, and moderator of the Dutch Diabeloop Facebook group. She has lived with Type 1 diabetes herself for 26 years and is passionate about helping other diabetes patients find their way in the diabetes world.}}

_{^{Declaration of Conflict of Interest
The reviewer has nothing to declare}}

_{^{Declaration of Financial Support
The reviewer hasn’t received any financial support of DiabetoTech for her contribution to the Diabetes Technology Expert program}}

_{^{Kate Hawke
Canada}}

_{^{I am an Australian endocrinologist completing a Diabetes Technology Fellowship at BCDiabetes, Vancouver with Dr Tom Elliott, University of British Columbia.}}

_{^{I work with people using diabetes technologies including open-source automated insulin delivery systems, and am undertaking clinical research on these systems. I have a special interest in type 1 diabetes in pregnancy.}}

_{^{Disclosures
No disclosures}}

_{^{Declaration of Financial Support
I received financial support from the following Australian organisations for my Diabetes Technology Fellowship: Royal Australasian College of Physicians Queensland Regional Committee, Medical Indemnity Group Australia, Logan Endocrinology and Diabetes Service.}}

_{^{Melissa Holloway
London, UK}}

_{^{Melissa Holloway is a passionate diabetes advocate, having lived with type 1 diabetes since 1994 and working in the diabetes care industry since 2003. She specializes in communicating about diabetes technology, including insulin pump therapy, CGM, and DIY artificial pancreas systems. From 2013 to 2018, she helped run the UK diabetes technology access advocacy organization, INPUT (now part of JDRF UK).}}

_{^{Declaration of Conflict of Interest
The reviewer has received honoraria or consulting/project fees from Abbott, Ascensia, Dexcom, Insulet and Roche Diabetes Care.}}

_{^{Declaration of Financial Support
The reviewer did not receive financial support of DiabetoTech for her contribution to the Diabetes Technology Expert Program.}}

_{^{Rosaline Jongeneelen
The Netherlands}}

<sub><sup>Rosaline Jongeneelen has type 1 diabetes since 2005. In 2022 she started with the Tandem pump in combination with the Dexcom G6.

Declaration of Conflict of Interest
The reviewer is a volunteer at Diabetes+, a Dutch diabetes foundation for and by people with type 1 diabetes.</sup></sub>

_{^{Declaration of Financial Support
The reviewer receives financial support of DiabetoTech for her contribution to the Diabetes Technology Expert program.}}

_{^{Veerle Kerckvoorde
Belgium}}

_{^{Veerle Kerckvoorde is a T1D patient since 38 years, mother of 2 adult sons and satisfied OMNIPOD-user since 07/2022. Professionally she works in IT, in her spare time she likes small walks and gardening.}}

_{^{Declaration of Conflict of Interest and Financial Support
I hereby wish to inform you of my involvement as a reviewer in the evaluation of the ‘OMNIPOD Dash’ for use in the Diabetes Technology Expert Program. It is of utmost importance to me to be transparent and forthright about my role to ensure the integrity and credibility of the program.}}

_{^{As a reviewer, I critically assessed ‘OMNIPOD Dash’ and provided feedback to contribute to its quality and relevance for the Diabetes Technology Expert Program.}}

_{^{It is important to note that my contribution as a reviewer does not entail any financial interest, business relationship, or any other potential conflict of interest concerning the Diabetes Technology Expert Program.}}

_{^{I am honored to have had the opportunity to contribute to the development of this valuable educational initiative, and I am committed to maintaining objectivity in my role as a reviewer.}}

_{^{Chelsea Lugone
United States of America}}

_{^{Chelsea Lugone, MSN, FNP-BC, CDCES is a dedicated Nurse Practitioner who is deeply passionate about supporting and empowering people impacted by diabetes. Her expertise and compassion make her an invaluable advocate in the field. Chelsea lives with Type 1 Diabetes as do two of her children. Chelsea wears the iLet insulin pump with Dexcom G7. Outside of work, Chelsea loves to travel and cherishes time spent with her family.}}

_{^{Disclosures
The reviewer is employed by Dexcom as a Medical Science Liaison.}}

_{^{Declaration of Financial Support
The reviewer has received speaker's fee of Sanofi and Provention Bio.}}

_{^{Christophe Merlot
Antwerp, Belgium}}

_{^{His T1 diabetes was diagnosed when he was 1 year old (in 1968).}}

_{^{He grew up and got passionated by technology and sports. Christophe works as an engineer in a high tech company. Next to his badminton activities (player and coach) he's also interested in wine tasting.}}

<sub><sup>In 2005, another immunity deficiency was diagnosed (Sarcoidoses) which caused a lot of extra burden on top of the T1 diabetes management.

He's been active as a volunteer in the "Diabetes Liga" since its creation.</sup></sub>

_{^{He started looping in January 2023 with Omnipod Dash & FreeStyle Libre 2, and he's actively assisting the new users via the social media communities on iAPS.}}

_{^{Disclosures
No disclosures}}

_{^{Declaration of Financial Support
The reviewer did not receive financial support of Diabetotech for his contribution to the Diabetes Technology Expert Program}}

_{^{Gary Scheiner
Philadelphia, USA}}

_{^{Gary Scheiner is owner and Clinical Director of Integrated Diabetes Services, a practice located just outside of Philadelphia specializing in intensive insulin therapy and advanced education for children and adults. Gary has been a Certified Diabetes Care & Education Specialist since 1995 and has lived with Type-1 diabetes since 1985. Gary was named 2014 Diabetes Educator of the Year by the American Association of Diabetes Educators. He has written seven books, including “Think Like A Pancreas-A Practical Guide to Managing Diabetes With Insulin”. He lectures nationally and internationally for people with diabetes as well as professionals in the healthcare industry. Gary is an active volunteer for several organizations, including JDRF, ADA, Diabetes Sisters, and the Diabetes Link.}}

_{^{Declaration of Conflict of Interest
The reviewer is a certified pump trainer for Medtronic, Tandem and Insulet. Serve on Speakers' bureaus for Dexcom, Eversense (Ascensia) and Xeris Pharma. Consultant to Triple Jump, Lilly, Adocia, Byram Healthcare, SweetSpot, Kilo Health, and Provention Bio.}}

_{^{Declaration of Financial Support
The reviewer receives financial support of DiabetoTech for his contribution to the Diabetes Technology Expert program}}

_{^{Dr Sarah Siegelaar
Amsterdam}}

_{^{Sarah Siegelaar is a board certified internist-endocrinologist and clinical researcher in Amsterdam UMC, Amsterdam, the Netherlands with special focus on diabetes during pregnancy and menopause, diabetes technology and in-hospital glucose regulation.}}

_{^{Disclosures
Sarah Siegelaar has made webinars and a podcast on time in range, diabetes technology and diabetes in pregnancy in cooperation with Abbott Diabetes, Medtronic, Eli Lilly, and Sanofi, and has served in advisory boards from Novo Nordisk and Eli Lilly.}}

_{^{Declaration of Financial Support
The reviewer doesn’t receive financial support of DiabetoTech for her contribution to the Diabetes Technology Expert program}}

_{^{Davor Skeledžija
Croatia}}

_{^{Davor Skeledzija is the Editor-in-Chief of NaInzulinu.com, where he leads a team dedicated to providing valuable content and resources for the diabetes community. With extensive experience in IT system integration and advocacy, he is passionate about bridging the gap between healthcare advancements and those living with diabetes.}}

_{^{Disclosures
No disclosures}}

_{^{Declaration of Financial Support
The reviewer received no financial support of DiabetoTech for her contribution to the Diabetes Technology Expert Program}}

_{^{Tim Street
London, UK}}

_{^{With over three decades of personal experience navigating type 1 diabetes, Tim Street is the author behind the renowned blog Diabettech, where the worlds of diabetes and technology seamlessly intertwine.}}

_{^{Disclosures
No disclosures}}

_{^{Declaration of Financial Support
The reviewer did not receive financial support of DiabetoTech for his contribution to the Diabetes Technology Expert Program}}

_{^{Daniella Struijk
Netherlands}}

_{^{Daniëlla Struijk is working in a hospital in the Netherlands as adult diabetes educator, specializing in both type 1 and complex type 2 diabetes care. She have had type 1 diabetes for almost 30 years and in the past she challanged herself to run marathons utilizing diabetes technology. She find it challenging to explore how diabetes technology can contribute to each person’s individual goals. She is passionate about helping others improve their diabetes management.}}

_{^{Disclosures
Reviewer has not received financial support from medical company in the past 3 years}}

_{^{Declaration of Financial Support
The reviewer did not receive financial support of DiabetoTech for her contribution to the Diabetes Technology Expert Program.}}

_{^{Dr Inge Van Boxelaer
Ghent, Belgium}}

_{^{Dr. Inge Van Boxelaer works as an endocrinologist at the General Hospital St-Lucas in Ghent, Belgium. Her expertise lies in the field of diabetes technology, and she is the founder of Diabetotech. Additionally, she holds the position of President at the Belgian professional Society of Endocrino-Diabetologists and serves as a board member of the Diabetes Liga. Dr. Van Boxelaer also contributes to the advisory boards of Diabetes Plus and Diabeter.}}

_{^{Declaration of Conflict of Interest
The author has received a speaker’s fee of Abbott, Novo Nordisk, Medtronic, Menarini, Sanofi and ViCentra.}}

_{^{Declaration of Financial Support
The author receives financial support of DiabetoTech for her contribution to the Diabetes Technology Expert Program}}

_{^{Cathy Van de Moortele
Belgium}}

_{^{Cathy has had type 1 diabetes for 21 years, diagnosed at the age of 30. A wife, a mother of 2, with a passion for cooking and baking, Cathy works as a kitchen assistant in a refugee center in the neighbourhood. She blogs for Aan Tafel met Type 1 diabetes and supports the We are not waiting diabetes community by DIY Looping with AndroidAPS/Dana-i/Dexcom G6.}}

_{^{Declaration of Conflict of Interest
Nothing to declare}}

_{^{Declaration of Financial Support
The reviewer did not receive financial support of DiabetoTech for her contribution to the Diabetes Technology Expert Program}}

_{^{Theo Van Elsberg
The Netherlands}}

_{^{Theo van Elsberg (NL, Professional Software/Cloud Engineer, Linkedin)
Have been working with AndroidAPS since June 2019, collaborating in development, testing, support and documentation on the initial AndroidAPS driver integrations for the Omnipod EROS and DASH patch pumps.}}

_{^{You can reach us at Discord: theodoor5137, #WeAreNotWaiting #androidaps}}

_{^{Declaration of Conflict of Interest
The reviewer hasn’t received any speaker’s fee.}}

_{^{Declaration of Financial Support
The reviewer doesn’t receive financial support of DiabetoTech for her contribution to the Diabetes Technology Expert program.}}

_{^{Dr Liesbeth Van Huffel
Aalst, Belgium}}

_{^{Dr. Liesbeth Van Huffel is an enthusiastic endocrinologist at OLV Hospital Aalst in Belgium with a strong interest in diabetes technology. She  is well-regarded for her patient-oriented perspective, expertise and passion for improving patient outcomes through technology.}}

_{^{Declaration of Conflict of Interest
The reviewer received consulting and speaking fees from Abbott, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Medtronic, Merck Sharp and Dohme, Novo Nordisk, and Sanofi-Aventis. She serves or has served on the advisory panel for Abbott, Roche, MSD.}}

_{^{Declaration of Financial Support
The reviewer received no financial support of DiabetoTech for her contribution to the Diabetes Technology Expert Program}}

_{^{Tom Vesely
Switzerland}}

_{^{Tom was diagnosed with type 1 diabetes at the age of 3. He has been spending more time to further enhance his knowledge of both type 1 and type 2 diabetes. He found his passion in various tools for diabetes management, such as continuous glucose monitors (CGM), insulin pumps, and automated insulin delivery systems.}} 

_{^{Disclosures
No disclosures}}

_{^{Declaration of Financial Support
The reviewer receives financial support of DiabetoTech for his contribution to the Diabetes Technology Expert program}}

_{^{Per Winterdijk
Netherlands}}

_{^{I am a Pediatric-Diabetologist at Diabeter, an independent treatment clinic for the treatment of T1D. Diabeter has 5 clinics in the Netherlands and I am primarily working in our Deventer departement. I have a keen interest in diabetes technology especially in the use of predictive algorithms, commercial and Open Source. I strive to improve the quality of life of persons living with diabetes, one of many the factors to do this is making sure to chose the right algorithm and help optimizing the settings. I am also a person living with diabetes.}}

_{^{Disclosures
No disclosures}}

_{^{Declaration of Financial Support
The reviewer did not receive financial support from DiabetoTech for his contribution to the Diabetes Technology Expert Program.}}